Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 1;156(8):918-921.
doi: 10.1001/jamadermatol.2020.1984.

Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion

Mary L Stevenson  1 , Maressa C Criscito  1 , Reason Wilken  1 , Nicole A Doudican  1 , Earl Eugene Bain 3rd  2 , Bhupesh Parashar  3 , John A Carucci  1
Affiliations

Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion

Mary L Stevenson et al. JAMA Dermatol. .

Abstract

This cohort study compares the use of adjuvant radiotherapy following surgery with surgery alone in patients treated for cutaneous squamous cell carcinoma with perineural invasion.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: This work was supported by a young investigator award in Dermatologic Surgery from the Dermatology Foundation (Dr Stevenson). No other disclosures were reported.

Figures

Figure.
Figure.. Disease-Free Survival
The estimated 5-year disease-free survival rate for patients treated with adjuvant radiotherapy was 100% (95% CI, 100%-100%) vs 68.8% (95% CI, 60.9%-76.7%) for those who did not receive adjuvant radiotherapy (P = .01).
See this image and copyright information in PMC

References

    1. Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(4):419-428. doi:10.1001/jamadermatol.2015.4994 - DOI - PMC - PubMed
    1. Miller J, Chang T, Schwartz D, Peters M, Baum C. Outcomes of adjuvant radiotherapy following negative surgical margins for cutaneous squamous cell carcinoma. Dermatol Surg. 2019;45(9):1111-1116. doi:10.1097/DSS.0000000000001827 - DOI - PubMed
    1. Jambusaria-Pahlajani A, Miller CJ, Quon H, Smith N, Klein RQ, Schmults CD. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg. 2009;35(4):574-585. doi:10.1111/j.1524-4725.2009.01095.x - DOI - PubMed
    1. Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29(7):621-631. doi:10.1002/hed.20576 - DOI - PubMed
    1. National Comprehensive Cancer Network Cutaneous squamous cell carcinoma. 2017.